SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Morgan Stanley Maintains Equal-Weight on Incyte, Lowers Price Target to $83

Morgan Stanley analyst Matthew Harrison maintains Incyte (NASDAQ:INCY) with a Equal-Weight and lowers the price target from $89 to $83.

Benzinga · 01/06/2020 14:13

Morgan Stanley analyst Matthew Harrison maintains Incyte (NASDAQ:INCY) with a Equal-Weight and lowers the price target from $89 to $83.